Jurj Ancuta, Paul Doru, Calin George A
Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 422, Houston, TX, 77030, USA.
Medical Oncology, Weill Cornell Medical College (WCMC) New York, New York, NY, USA.
BMC Cancer. 2025 Jul 8;25(1):1154. doi: 10.1186/s12885-025-14375-7.
Cancer progression, along with other hallmarks of cancer, is sustained through bidirectional cell-to-cell communication. This function is primarily facilitated by lipid-rich nanoparticles expelled into the extracellular matrix by stromal and/or malignant cells. These entities, known as extracellular vesicles, contain a vast repertoire of bioactive molecules and hold promise as potential biomarkers and nanovehicles for drug delivery. Intriguingly, the cellular and molecular mechanisms governing the functions of extracellular vesicles remain poorly understood. In the present manuscript, we highlight the intracellular and intercellular journey of extracellular vesicles, from their inception to the present day, their implications in various hallmarks of cancer, and their clinical applications.
癌症进展以及癌症的其他特征是通过细胞间双向通讯得以维持的。这种功能主要由基质细胞和/或恶性细胞排出到细胞外基质中的富含脂质的纳米颗粒所促进。这些被称为细胞外囊泡的实体包含大量生物活性分子,有望成为潜在的生物标志物和药物递送纳米载体。有趣的是,目前对调控细胞外囊泡功能的细胞和分子机制仍知之甚少。在本手稿中,我们重点介绍了细胞外囊泡从产生到现在的细胞内和细胞间历程、它们在癌症各种特征中的意义以及它们的临床应用。